Supreme Courts of Arkansas Reverses $1.2 Billion Judgments in Risperdal Labeling Case, Declares FDA “Warning Letters” Inadmissible Evidence Read more
US v. Caronia, One Year Later: FDA’s Position on Off-Label Promotion Remains the Same, But Changes are Looming Read more
Lance vs. Wyeth – PA Supreme Court: Pharmaceutical Companies Can Be Sued for Lack of “Due Care” by Introducing Dangerous Drugs to the Market Read more
CareFusion Settlement Features Corporate Regulatory Officer as Whistle Blower, Implicating High Profile Physicians Read more
Bioscrip Settles with DOJ, Novartis Accused of Paying Kickbacks to Pharmacies for Exjade Patient Adherence Program Read more
Supreme Court Rejection of Pfizer’s Request for RICO Off Label Review: Could Open Floodgate of Cases Read more
Judge Rules Disputes Over Medical Studies Should Be Resolved by Researchers and Scientists not Courts Read more
States Hiring Private Law Firms on Contingent Basis for Civil Actions Can Potentially Effect Life Science Companies Read more